Skip to content
10-Q

Quarterly Report

NORTHSTAR HEALTHCARE INCOME, INC.

0001503707-24-000049

← back to feed
Filed
Nov 8, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 7, 2024 185.71M sh
Shares Diluted Q3 2024 · Sep 30, 2024 185.71M sh
Shares Diluted Q3 2024 · Sep 30, 2024 185.71M sh
Shares Diluted Q3 2024 · Sep 30, 2023 185.71M sh
Shares Diluted Q3 2024 · Sep 30, 2023 191.37M sh
Stock Repurchased Q3 2024 · Sep 30, 2024 $0
Stock Repurchased Q3 2024 · Sep 30, 2023 $1.32M
Operating Cash Flow Q3 2024 · Sep 30, 2024 $16.74M
Operating Cash Flow Q3 2024 · Sep 30, 2023 $13.07M
Long Term Debt Q3 2024 · Sep 30, 2024 $879.75M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $333.26M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $85.04M
Stockholders Equity Q3 2024 · Sep 30, 2024 $239.43M
Stockholders Equity Q3 2024 · Dec 31, 2023 $132.89M
Total Liabilities Q3 2024 · Sep 30, 2024 $914.18M
Total Liabilities Q3 2024 · Dec 31, 2023 $927.74M
Total Assets Q3 2024 · Sep 30, 2024 $1.15B
Total Assets Q3 2024 · Dec 31, 2023 $1.06B
Eps Diluted Q3 2024 · Sep 30, 2024 $0.67
Eps Diluted Q3 2024 · Sep 30, 2024 $0.57
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.06
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.43
Eps Basic Q3 2024 · Sep 30, 2024 $0.67
Eps Basic Q3 2024 · Sep 30, 2024 $0.57
Eps Basic Q3 2024 · Sep 30, 2023 −$0.06
Eps Basic Q3 2024 · Sep 30, 2023 −$0.43
Sga Expense Q3 2024 · Sep 30, 2024 $2.8M
Sga Expense Q3 2024 · Sep 30, 2024 $9.27M
Sga Expense Q3 2024 · Sep 30, 2023 $2.92M
Sga Expense Q3 2024 · Sep 30, 2023 $10.42M
Gross Profit Q3 2024 · Sep 30, 2024 $19.73M
Gross Profit Q3 2024 · Sep 30, 2024 $52.94M
Gross Profit Q3 2024 · Sep 30, 2023 $16.48M
Gross Profit Q3 2024 · Sep 30, 2023 $47.45M
Cost Of Revenue Q3 2024 · Sep 30, 2024 $32.89M
Cost Of Revenue Q3 2024 · Sep 30, 2024 $98.69M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $36.89M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $106.99M
Revenue Q3 2024 · Sep 30, 2024 $52.62M
Revenue Q3 2024 · Sep 30, 2024 $151.63M
Revenue Q3 2024 · Sep 30, 2023 $53.37M
Revenue Q3 2024 · Sep 30, 2023 $154.45M